Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
The global Clinical Mass Spectrometry market size is expected to reach US$ 1647.8 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Mass Spectrometry in various end use industries. The expanding demands from the Clinical Diagnostics and Clinical Research, are propelling Clinical Mass Spectrometry market. LC-MS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the MALDI-TOF MS segment is estimated at % CAGR for the next seven-year period.
Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Mass Spectrometry, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Mass Spectrometry market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Mass Spectrometry market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Mass Spectrometry sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Mass Spectrometry covered in this report include Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu and Perkin Elmer, etc.
The global Clinical Mass Spectrometry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Clinical Mass Spectrometry market, by region:
Global Clinical Mass Spectrometry market, Segment by Type:
Global Clinical Mass Spectrometry market, by Application
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Clinical Mass Spectrometry manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Clinical Mass Spectrometry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Clinical Mass Spectrometry Market Overview
1.1 Clinical Mass Spectrometry Product Overview
1.2 Clinical Mass Spectrometry Market Segment by Type
1.2.1 LC-MS
1.2.2 MALDI-TOF MS
1.2.3 Other
1.3 Global Clinical Mass Spectrometry Market Size by Type
1.3.1 Global Clinical Mass Spectrometry Market Size Overview by Type (2018-2029)
1.3.2 Global Clinical Mass Spectrometry Historic Market Size Review by Type (2018-2023)
1.3.3 Global Clinical Mass Spectrometry Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Clinical Mass Spectrometry Sales Breakdown by Type (2018-2023)
1.4.2 Europe Clinical Mass Spectrometry Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Clinical Mass Spectrometry Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Clinical Mass Spectrometry Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Clinical Mass Spectrometry Sales Breakdown by Type (2018-2023)
2 Global Clinical Mass Spectrometry Market Competition by Company
2.1 Global Top Players by Clinical Mass Spectrometry Sales (2018-2023)
2.2 Global Top Players by Clinical Mass Spectrometry Revenue (2018-2023)
2.3 Global Top Players by Clinical Mass Spectrometry Price (2018-2023)
2.4 Global Top Manufacturers Clinical Mass Spectrometry Manufacturing Base Distribution, Sales Area, Product Type
2.5 Clinical Mass Spectrometry Market Competitive Situation and Trends
2.5.1 Clinical Mass Spectrometry Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Clinical Mass Spectrometry Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2022)
2.7 Date of Key Manufacturers Enter into Clinical Mass Spectrometry Market
2.8 Key Manufacturers Clinical Mass Spectrometry Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Clinical Mass Spectrometry Status and Outlook by Region
3.1 Global Clinical Mass Spectrometry Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Clinical Mass Spectrometry Historic Market Size by Region
3.2.1 Global Clinical Mass Spectrometry Sales in Volume by Region (2018-2023)
3.2.2 Global Clinical Mass Spectrometry Sales in Value by Region (2018-2023)
3.2.3 Global Clinical Mass Spectrometry Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Clinical Mass Spectrometry Forecasted Market Size by Region
3.3.1 Global Clinical Mass Spectrometry Sales in Volume by Region (2024-2029)
3.3.2 Global Clinical Mass Spectrometry Sales in Value by Region (2024-2029)
3.3.3 Global Clinical Mass Spectrometry Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Clinical Mass Spectrometry by Application
4.1 Clinical Mass Spectrometry Market Segment by Application
4.1.1 Clinical Diagnostics
4.1.2 Clinical Research
4.2 Global Clinical Mass Spectrometry Market Size by Application
4.2.1 Global Clinical Mass Spectrometry Market Size Overview by Application (2018-2029)
4.2.2 Global Clinical Mass Spectrometry Historic Market Size Review by Application (2018-2023)
4.2.3 Global Clinical Mass Spectrometry Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Clinical Mass Spectrometry Sales Breakdown by Application (2018-2023)
4.3.2 Europe Clinical Mass Spectrometry Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Clinical Mass Spectrometry Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Clinical Mass Spectrometry Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Clinical Mass Spectrometry Sales Breakdown by Application (2018-2023)
5 North America Clinical Mass Spectrometry by Country
5.1 North America Clinical Mass Spectrometry Historic Market Size by Country
5.1.1 North America Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Clinical Mass Spectrometry Sales in Volume by Country (2018-2023)
5.1.3 North America Clinical Mass Spectrometry Sales in Value by Country (2018-2023)
5.2 North America Clinical Mass Spectrometry Forecasted Market Size by Country
5.2.1 North America Clinical Mass Spectrometry Sales in Volume by Country (2024-2029)
5.2.2 North America Clinical Mass Spectrometry Sales in Value by Country (2024-2029)
6 Europe Clinical Mass Spectrometry by Country
6.1 Europe Clinical Mass Spectrometry Historic Market Size by Country
6.1.1 Europe Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Clinical Mass Spectrometry Sales in Volume by Country (2018-2023)
6.1.3 Europe Clinical Mass Spectrometry Sales in Value by Country (2018-2023)
6.2 Europe Clinical Mass Spectrometry Forecasted Market Size by Country
6.2.1 Europe Clinical Mass Spectrometry Sales in Volume by Country (2024-2029)
6.2.2 Europe Clinical Mass Spectrometry Sales in Value by Country (2024-2029)
7 Asia-Pacific Clinical Mass Spectrometry by Region
7.1 Asia-Pacific Clinical Mass Spectrometry Historic Market Size by Region
7.1.1 Asia-Pacific Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Clinical Mass Spectrometry Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Clinical Mass Spectrometry Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Clinical Mass Spectrometry Forecasted Market Size by Region
7.2.1 Asia-Pacific Clinical Mass Spectrometry Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Clinical Mass Spectrometry Sales in Value by Region (2024-2029)
8 Latin America Clinical Mass Spectrometry by Country
8.1 Latin America Clinical Mass Spectrometry Historic Market Size by Country
8.1.1 Latin America Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Clinical Mass Spectrometry Sales in Volume by Country (2018-2023)
8.1.3 Latin America Clinical Mass Spectrometry Sales in Value by Country (2018-2023)
8.2 Latin America Clinical Mass Spectrometry Forecasted Market Size by Country
8.2.1 Latin America Clinical Mass Spectrometry Sales in Volume by Country (2024-2029)
8.2.2 Latin America Clinical Mass Spectrometry Sales in Value by Country (2024-2029)
9 Middle East and Africa Clinical Mass Spectrometry by Country
9.1 Middle East and Africa Clinical Mass Spectrometry Historic Market Size by Country
9.1.1 Middle East and Africa Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Clinical Mass Spectrometry Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Clinical Mass Spectrometry Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Clinical Mass Spectrometry Forecasted Market Size by Country
9.2.1 Middle East and Africa Clinical Mass Spectrometry Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Clinical Mass Spectrometry Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Danaher
10.1.1 Danaher Company Information
10.1.2 Danaher Introduction and Business Overview
10.1.3 Danaher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Danaher Clinical Mass Spectrometry Products Offered
10.1.5 Danaher Recent Development
10.2 Bruker
10.2.1 Bruker Company Information
10.2.2 Bruker Introduction and Business Overview
10.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bruker Clinical Mass Spectrometry Products Offered
10.2.5 Bruker Recent Development
10.3 Agilent
10.3.1 Agilent Company Information
10.3.2 Agilent Introduction and Business Overview
10.3.3 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Agilent Clinical Mass Spectrometry Products Offered
10.3.5 Agilent Recent Development
10.4 Thermo Fisher
10.4.1 Thermo Fisher Company Information
10.4.2 Thermo Fisher Introduction and Business Overview
10.4.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Thermo Fisher Clinical Mass Spectrometry Products Offered
10.4.5 Thermo Fisher Recent Development
10.5 Waters
10.5.1 Waters Company Information
10.5.2 Waters Introduction and Business Overview
10.5.3 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Waters Clinical Mass Spectrometry Products Offered
10.5.5 Waters Recent Development
10.6 Shidmazu
10.6.1 Shidmazu Company Information
10.6.2 Shidmazu Introduction and Business Overview
10.6.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shidmazu Clinical Mass Spectrometry Products Offered
10.6.5 Shidmazu Recent Development
10.7 Perkin Elmer
10.7.1 Perkin Elmer Company Information
10.7.2 Perkin Elmer Introduction and Business Overview
10.7.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Perkin Elmer Clinical Mass Spectrometry Products Offered
10.7.5 Perkin Elmer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Clinical Mass Spectrometry Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Clinical Mass Spectrometry Industrial Chain Analysis
11.4 Clinical Mass Spectrometry Market Dynamics
11.4.1 Clinical Mass Spectrometry Industry Trends
11.4.2 Clinical Mass Spectrometry Market Drivers
11.4.3 Clinical Mass Spectrometry Market Challenges
11.4.4 Clinical Mass Spectrometry Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Clinical Mass Spectrometry Distributors
12.3 Clinical Mass Spectrometry Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research